These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

609 related articles for article (PubMed ID: 19359436)

  • 1. Toll-like receptors as targets in chronic liver diseases.
    Mencin A; Kluwe J; Schwabe RF
    Gut; 2009 May; 58(5):704-20. PubMed ID: 19359436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Toll-like receptors in liver health and disease.
    Broering R; Lu M; Schlaak JF
    Clin Sci (Lond); 2011 Nov; 121(10):415-26. PubMed ID: 21797822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-like receptors in acute liver injury and regeneration.
    Chen Y; Sun R
    Int Immunopharmacol; 2011 Oct; 11(10):1433-41. PubMed ID: 21601014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll-like receptors and kidney diseases.
    Eleftheriadis T; Lawson BR
    Inflamm Allergy Drug Targets; 2009 Jul; 8(3):191-201. PubMed ID: 19601879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The innate immune system, toll-like receptors and dermal wound healing: A review.
    Portou MJ; Baker D; Abraham D; Tsui J
    Vascul Pharmacol; 2015 Aug; 71():31-6. PubMed ID: 25869514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the innate immune system in atherosclerotic disease.
    Oude Nijhuis MM; van Keulen JK; Pasterkamp G; Quax PH; de Kleijn DP
    Curr Pharm Des; 2007; 13(10):983-94. PubMed ID: 17430162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Innate immunity: cutaneous expression of Toll-like receptors].
    Musette P; Auquit Auckbur I; Begon E
    Med Sci (Paris); 2006 Feb; 22(2):149-52. PubMed ID: 16457754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-like receptors in inflammation of the central nervous system.
    Kong Y; Le Y
    Int Immunopharmacol; 2011 Oct; 11(10):1407-14. PubMed ID: 21600311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Toll-Like Receptors in Skin Host Defense, Psoriasis, and Atopic Dermatitis.
    Sun L; Liu W; Zhang LJ
    J Immunol Res; 2019; 2019():1824624. PubMed ID: 31815151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of the Innate Immune Response by Targeting Toll-like Receptors: A Perspective on Their Agonists and Antagonists.
    Federico S; Pozzetti L; Papa A; Carullo G; Gemma S; Butini S; Campiani G; Relitti N
    J Med Chem; 2020 Nov; 63(22):13466-13513. PubMed ID: 32845153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct and indirect role of Toll-like receptors in T cell mediated immunity.
    Xu D; Liu H; Komai-Koma M
    Cell Mol Immunol; 2004 Aug; 1(4):239-46. PubMed ID: 16225766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptors in liver disease.
    Petrasek J; Csak T; Szabo G
    Adv Clin Chem; 2013; 59():155-201. PubMed ID: 23461136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recognition of pathogenic microorganisms by Toll-like receptors.
    Netea MG; Van der Meer JW; Kullberg BJ
    Drugs Today (Barc); 2006 Mar; 42 Suppl A():99-105. PubMed ID: 16683049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-like receptors and their role in renal pathologies.
    Eleftheriadis T; Pissas G; Liakopoulos V; Stefanidis I; Lawson BR
    Inflamm Allergy Drug Targets; 2012 Dec; 11(6):464-77. PubMed ID: 22931389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RAGE and TLRs: relatives, friends or neighbours?
    Ibrahim ZA; Armour CL; Phipps S; Sukkar MB
    Mol Immunol; 2013 Dec; 56(4):739-44. PubMed ID: 23954397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like receptors in angiogenesis.
    Grote K; Schütt H; Schieffer B
    ScientificWorldJournal; 2011 Apr; 11():981-91. PubMed ID: 21516292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrinsic danger: activation of Toll-like receptors in rheumatoid arthritis.
    Goh FG; Midwood KS
    Rheumatology (Oxford); 2012 Jan; 51(1):7-23. PubMed ID: 21984766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Innate immunity and toll-like receptor antagonists: a potential role in the treatment of cardiovascular diseases.
    Lin E; Freedman JE; Beaulieu LM
    Cardiovasc Ther; 2009; 27(2):117-23. PubMed ID: 19426249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toll-like Receptors in the Vascular System: Sensing the Dangers Within.
    Goulopoulou S; McCarthy CG; Webb RC
    Pharmacol Rev; 2016 Jan; 68(1):142-67. PubMed ID: 26721702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptors in liver fibrosis: cellular crosstalk and mechanisms.
    Yang L; Seki E
    Front Physiol; 2012; 3():138. PubMed ID: 22661952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.